Related Experiment Videos
Gastric mucosal protection by sucralfate involves phosphoinositides participation
A Slomiany1, K Mizuta, J Piotrowski
1Research Center, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark 07103-2400.
The International Journal of Biochemistry
|January 1, 1990
Summary
Sucralfate protects the gastric mucosa from damage by ethanol and indomethacin. Its gastroprotective action involves enhanced phosphoinositide metabolism, not prostaglandins.
Area of Science:
- Gastroenterology
- Pharmacology
- Cell Biology
Background:
- Sucralfate is an antiulcer drug with known gastroprotective effects.
- The precise mechanism underlying sucralfate's protective action requires further elucidation.
- Previous studies suggest a role for prostaglandins, but this remains debated.
Purpose of the Study:
- To investigate the mechanism of gastroprotection by sucralfate.
- To determine if sucralfate's action is mediated by endogenous prostaglandins.
- To explore the role of phosphoinositide metabolism in sucralfate's gastroprotective effects.
Main Methods:
- In vivo studies using rats with and without indomethacin pretreatment, followed by ethanol administration.
- In vitro studies involving cultured gastric mucosa exposed to sucralfate and indomethacin.
- Analysis of gastric mucus gel dimensions, mucin content, and mucosal phosphoinositide turnover.
Main Results:
- Sucralfate significantly reduced ethanol-induced gastric lesions in vivo.
- Sucralfate prevented indomethacin's detrimental effects on gastric mucus.
- Sucralfate enhanced mucosal phosphoinositide turnover, specifically activating phospholipase C.
- Sucralfate's effects were independent of endogenous prostaglandins.
Conclusions:
- Sucralfate's gastroprotective mechanism is not mediated by prostaglandins.
- Sucralfate's action involves the metabolism of phosphoinositide-derived messenger molecules.
- Sucralfate enhances gastric mucosal defense through modulation of cellular signaling pathways.